Medical Cannabis for Gilles de la Tourette Syndrome: An Open-Label Prospective Study.
Saar AnisCorinne ZalomekAmos D KorczynAlina RosenbergNir GiladiTanya GurevichPublished in: Behavioural neurology (2022)
MC treatment demonstrates good efficacy and tolerability in adult GTS patients. Predilection for smoking rather than using oil drops requires further comparative studies to evaluate the efficacy of each. Cognitive and psychiatric side effects have to be monitored and addressed.
Keyphrases
- end stage renal disease
- ejection fraction
- newly diagnosed
- healthcare
- chronic kidney disease
- mental health
- prognostic factors
- peritoneal dialysis
- open label
- randomized controlled trial
- clinical trial
- smoking cessation
- fatty acid
- patient reported outcomes
- combination therapy
- young adults
- patient reported
- childhood cancer